ESR1 and neoplasm: Comparatively large Dkk1 concentrations reduced BC-SC numbers down to 25 percent of controls in MCF-7 cells, whereas MCF7 cells differed from primary tumor cells in response to low dose Dkk1, even though these cells were of the same ER+ breast cancer phenotype.